These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 28267162)
21. Microphysiological Systems: A Pathologist's Perspective. Sura R; Van Vleet T; Berridge BR Vet Pathol; 2020 May; 57(3):358-368. PubMed ID: 32180532 [TBL] [Abstract][Full Text] [Related]
22. Kinetic analysis of sequential metabolism of triazolam and its extrapolation to humans using an entero-hepatic two-organ microphysiological system. Arakawa H; Sugiura S; Kawanishi T; Shin K; Toyoda H; Satoh T; Sakai Y; Kanamori T; Kato Y Lab Chip; 2020 Feb; 20(3):537-547. PubMed ID: 31930237 [TBL] [Abstract][Full Text] [Related]
23. An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment. Marin TM; Indolfo NC; Rocco SA; de Carvalho M; Dias MM; Vasconcelos Bento GI; Bortot LO; Schuck DC; Lorencini M; Pagani E J Vis Exp; 2020 Dec; (166):. PubMed ID: 33346185 [TBL] [Abstract][Full Text] [Related]
24. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact. Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521 [TBL] [Abstract][Full Text] [Related]
25. Microphysiological systems in absorption, distribution, metabolism, and elimination sciences. Van Ness KP; Cesar F; Yeung CK; Himmelfarb J; Kelly EJ Clin Transl Sci; 2022 Jan; 15(1):9-42. PubMed ID: 34378335 [TBL] [Abstract][Full Text] [Related]
27. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198 [TBL] [Abstract][Full Text] [Related]
28. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods? Björkman S Clin Pharmacokinet; 2006; 45(1):1-11. PubMed ID: 16430308 [TBL] [Abstract][Full Text] [Related]
29. Characterization of application scenario-dependent pharmacokinetics and pharmacodynamic properties of permethrin and hyperforin in a dynamic skin and liver multi-organ-chip model. Kühnl J; Tao TP; Brandmair K; Gerlach S; Rings T; Müller-Vieira U; Przibilla J; Genies C; Jaques-Jamin C; Schepky A; Marx U; Hewitt NJ; Maschmeyer I Toxicology; 2021 Jan; 448():152637. PubMed ID: 33220337 [TBL] [Abstract][Full Text] [Related]
30. Translational prediction of first-in-human pharmacokinetics and pharmacodynamics of janagliflozin, a selective SGLT2 inhibitor, using allometric scaling, dedrick and PK/PD modeling methods. Song L; Yao X; Liu Y; Zhong W; Jiang J; Liu H; Zhou H; Shi C; Zong K; Wang C; Ma C; Liu D; Hu P Eur J Pharm Sci; 2020 Apr; 147():105281. PubMed ID: 32126254 [TBL] [Abstract][Full Text] [Related]
31. Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle. Vernetti L; Gough A; Baetz N; Blutt S; Broughman JR; Brown JA; Foulke-Abel J; Hasan N; In J; Kelly E; Kovbasnjuk O; Repper J; Senutovitch N; Stabb J; Yeung C; Zachos NC; Donowitz M; Estes M; Himmelfarb J; Truskey G; Wikswo JP; Taylor DL Sci Rep; 2017 Feb; 7():42296. PubMed ID: 28176881 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation and Clarification of Enterohepatic Interactions in Pharmacokinetics]. Arakawa H Yakugaku Zasshi; 2023; 143(2):101-104. PubMed ID: 36724921 [TBL] [Abstract][Full Text] [Related]
33. Interspecies scaling and comparisons in drug development and toxicokinetics. Ings RM Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215 [TBL] [Abstract][Full Text] [Related]
34. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects. Ribeiro AJS; Yang X; Patel V; Madabushi R; Strauss DG Clin Pharmacol Ther; 2019 Jul; 106(1):139-147. PubMed ID: 30993668 [TBL] [Abstract][Full Text] [Related]
35. Application of a gut-liver-on-a-chip device and mechanistic modelling to the quantitative Milani N; Parrott N; Ortiz Franyuti D; Godoy P; Galetin A; Gertz M; Fowler S Lab Chip; 2022 Jul; 22(15):2853-2868. PubMed ID: 35833849 [TBL] [Abstract][Full Text] [Related]
36. Amplifying the impact of kidney microphysiological systems: predicting renal drug clearance using mechanistic modelling based on reconstructed drug secretion. Caetano-Pinto P; Nordell P; Nieskens T; Haughan K; Fenner KS; Stahl SH ALTEX; 2023; 40(3):408-424. PubMed ID: 36343109 [TBL] [Abstract][Full Text] [Related]
37. Usefulness of a humanized tricellular static transwell blood-brain barrier model as a microphysiological system for drug development applications. - A case study based on the benchmark evaluations of blood-brain barrier microphysiological system. Nakayama-Kitamura K; Shigemoto-Mogami Y; Toyoda H; Mihara I; Moriguchi H; Naraoka H; Furihata T; Ishida S; Sato K Regen Ther; 2023 Mar; 22():192-202. PubMed ID: 36891355 [TBL] [Abstract][Full Text] [Related]
38. [Microphysiological system as a promising technology for drug assay]. Ishida S; Kanamori T Nihon Yakurigaku Zasshi; 2019; 154(6):345-351. PubMed ID: 31787688 [TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Abd Rahman AN; Tett SE; Staatz CE Clin Pharmacokinet; 2013 May; 52(5):303-31. PubMed ID: 23475567 [TBL] [Abstract][Full Text] [Related]
40. Liver microphysiological platforms for drug metabolism applications. Kulsharova G; Kurmangaliyeva A Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]